HIV infection, inflammation, immunosenescence, and aging
- PMID: 21090961
- PMCID: PMC3759035
- DOI: 10.1146/annurev-med-042909-093756
HIV infection, inflammation, immunosenescence, and aging
Abstract
Although antiretroviral therapy for HIV infection prevents AIDS-related complications and prolongs life, it does not fully restore health. Long-term treated patients remain at higher than expected risk for a number of complications typically associated with aging, including cardiovascular disease, cancer, osteoporosis, and other end-organ diseases. The potential effect of HIV on health is perhaps most clearly exhibited by a number of immunologic abnormalities that persist despite effective suppression of HIV replication. These changes are consistent with some of the changes to the adaptive immune system that are seen in the very old ("immunosenescence") and that are likely related in part to persistent inflammation. HIV-associated inflammation and immunosenescence have been implicated as causally related to the premature onset of other end-organ diseases. Novel therapeutic strategies aimed at preventing or reversing these immunologic defects may be necessary if HIV-infected patients are to achieve normal life span.
Similar articles
-
HIV infection and aging of the innate immune system.Sex Health. 2011 Dec;8(4):453-64. doi: 10.1071/SH11028. Sex Health. 2011. PMID: 22127030 Review.
-
[Inflammation and HIV].Bull Acad Natl Med. 2011 Mar;195(3):531-42; discussion 543-4. Bull Acad Natl Med. 2011. PMID: 22292303 Review. French.
-
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.Top HIV Med. 2009 Sep-Oct;17(4):118-23. Top HIV Med. 2009. PMID: 19890183
-
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76. AIDS. 2008. PMID: 18427202 Free PMC article.
-
Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.J Neurovirol. 2012 Aug;18(4):247-55. doi: 10.1007/s13365-011-0073-y. Epub 2011 Dec 29. J Neurovirol. 2012. PMID: 22205585 Review.
Cited by
-
The Impact of HIV and Parasite Single Infection and Coinfection on Telomere Length: A Systematic Review.Curr Issues Mol Biol. 2024 Jul 8;46(7):7258-7290. doi: 10.3390/cimb46070431. Curr Issues Mol Biol. 2024. PMID: 39057072 Free PMC article. Review.
-
Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV.iScience. 2024 May 8;27(6):109945. doi: 10.1016/j.isci.2024.109945. eCollection 2024 Jun 21. iScience. 2024. PMID: 38812553 Free PMC article.
-
Cardiac and Renal Comorbidities in Aging People Living With HIV.Circ Res. 2024 May 24;134(11):1636-1660. doi: 10.1161/CIRCRESAHA.124.323948. Epub 2024 May 23. Circ Res. 2024. PMID: 38781295 Free PMC article. Review.
-
Plasma Virome of HIV-infected Subjects on Suppressive Antiretroviral Therapy Reveals Association of Differentially Abundant Viruses with Distinct T-cell Phenotypes and Inflammation.Curr Genomics. 2024 Apr 8;25(2):105-119. doi: 10.2174/0113892029279786240111052824. Curr Genomics. 2024. PMID: 38751600
-
The Impact of Immune System Aging on Infectious Diseases.Microorganisms. 2024 Apr 11;12(4):775. doi: 10.3390/microorganisms12040775. Microorganisms. 2024. PMID: 38674719 Free PMC article. Review.
References
-
- Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51–59. - PubMed
-
- Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark,1995–2005. Ann. Intern. Med. 2007;146:87–95. - PubMed
-
- Justice AC. HIV and aging: time for a new paradigm. Curr. HIV/AIDS Rep. 2010;7:69–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AI071713/AI/NIAID NIH HHS/United States
- K24AI069994/AI/NIAID NIH HHS/United States
- K24 AI069994/AI/NIAID NIH HHS/United States
- P01AI071713/AI/NIAID NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- R01 AI087145/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R01HL095130/HL/NHLBI NIH HHS/United States
- P0 AI27763/AI/NIAID NIH HHS/United States
- R01 HL095130/HL/NHLBI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- 1 R24 AI067039-1/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical